Aarti Drugs Ltd
company logo

Aarti Drugs Ltd

Pharmaceuticals
Small Cap

-

0 (0%)


Aarti Drugs Ltd Performance

-

-

-

-


-

-

-

-

-

Aarti Drugs Ltd Fundamentals

4,831.64Cr

28.18

3.77

0.52

18.65

0.19%

139.40

i buttonClick here to know more about Fundamentals

Aarti Drugs Ltd Financials

Aarti Drugs Ltd Financialsright-arrow

Aarti Drugs Ltd Shareholding Pattern

Aarti Drugs Ltd Delivery and Volume

About Aarti Drugs Ltd

Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals. The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million. With over 50 compounds for Antibiotics, Anti Protozoal,

-

1984

AARTIDRUGS

NameDesignation
Prakash M PatilCMD & Executive Director
Rashesh C GogriED / MD / Promoter
Harshit M SavlaED / Joint MD / Promoter
Harit P ShahE D & Wholetime Director
Uday M PatilWTD & Executive Director
Narendra Jagannath SalviNon Executive Director
Navin Chapshi ShahIndependent Non Exe. Director
Krishnacharya G AkamanchiIndependent Non Exe. Director
Priti SavlaIndependent Non Exe. Director
Ankit Vikram PalejaIndependent Non Exe. Director
Bhaskar Narayan ThoratIndependent Non Exe. Director
Neha GadaIndependent Non Exe. Director
News and Events...

Similar Stocks

What's Trending

Aarti Drugs Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Aarti Drugs Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Aarti Drugs Ltd's share price is ₹528.6 as of 2024-07-27.
Aarti Drugs Ltd's P/E ratio is 28.18 times as of 2024-07-27.
Aarti Drugs Ltd's most recent financial reports indicate a price-to-book ratio of 3.77, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Aarti Drugs Ltd's market capitalization is ₹4831.64 Cr as on 2024-07-27.
The current financial records of Aarti Drugs Ltd show a 14.65% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Aarti Drugs Ltd's most recent financial filings, the company has a total asset value of ₹1349.53, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Aarti Drugs Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Aarti Drugs Ltd's 52-week high and low as of 2024-07-27 are ₹532.25 and ₹525.8, respectively.